منابع مشابه
Populations and polypills: if yes, then how?
For industrialised countries, control of cardiovascular disease (CVD) is the most important achievement of biomedicine in the last half-century—certainly in terms of decrease in disease burden. The orderly sequence of research, surveillance, trials and implementation organised by cardiovascular scientists has led to a decline of 80% for both coronary heart disease and stroke in the USA and othe...
متن کاملClot retrieval for stroke: 'yes we can,' but priority for trials and registries.
Few controversies have generated as much heat as the questions surrounding the role of clot retrieval. A core issue in this debate is the licensing of clot retrieval devices based solely on Phase II evidence. Our protagonists have excelled themselves in fueling the debate; as always, we will take a measured middle ground! In our careers, the proof of efficacy of intravenous tissue plasminogen a...
متن کاملEditorial: arthroplasty devices: registries and beyond.
I n spite of the overall technological progress and clinical success of orthopaedic devices, unexpected safety concerns, such as those reported for some metal-on-metal (MoM) total hip replacements [2], continue to attract substantial attention from patients, physicians, and policy makers. Recently, CORR’s Editor-inChief suggested that it can be ‘‘difficult to resist the lure of new technologies...
متن کاملEditorial comment: Clinical pathways: mediastinoscopy and mediastinal lymph node dissection.
phase III randomised controlled trial. Lancet 2009;374:379—86. [15] Pisters KM, Vallières E, Crowley JJ, Franklin WA, Bunn Jr PA, Ginsberg RJ, Putnam Jr JB, Chansky K, Gandara D. Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. J Clin Oncol 2010;28:1843—9. ...
متن کاملEditorial Comment: Therapeutic Orphans
By an odd and unfortunate twist of fate, infants and children are becoming “therapeutic or pharmaceutical orphans.”1 Since 1962 they have been denied the use of many new drugs. The Drug Laws of 1962 had their inception following a pediatric tragedy—the thalidomide catastrophe. The laws of 1938 followed another which resulted from the use of a pediatric dosage form, “elixir” of sulfanilamide. By...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Cardio-Thoracic Surgery
سال: 2013
ISSN: 1010-7940,1873-734X
DOI: 10.1093/ejcts/ezt083